Shopping cart ITEMS
 modern scholarly publishers in the finest tradition
Login Register
Home
Books
Journals
References
A-Z Index
Author Index
For Our Authors
User Area
Shopping Cart
Contact
Electronic Data Center

Critical Reviews™ in Eukaryotic Gene Expression

 

ISSN for PRINT: 1045-4403

Institutional price:

$708.00

Issues per year:

4

For Online Access

Best Paper Award Selection - Editorial Board Site

Add subscription to shopping cart

2002, Volume12

Issue 2

  78 pages  

DOI: 10.1615/CritRevEukaryotGeneExpr.v12.i2   

click 'Save as...' here to save XML metadata

Issue price - $169.00  

Add to shopping cart

  • Nuclear Receptor Regulation of Genes Involved in Bile Acid Metabolism
  • John T. Moore
    Discovery Research, GlaxoSmithKline, Research Triangle Park, NC 27709

    Bryan Goodwin
    Discovery Research, GlaxoSmithKline, Research Triangle Park, NC 27709

    Timothy M. Willson
    Discovery Research, GlaxoSmithKline, Research Triangle Park, NC 27709

    Steven A. Kliewer
    Discovery Research, GlaxoSmithKline, Research Triangle Park, NC 27709


    ABSTRACT

    Over the past few decades, the nuclear receptor superfamily of transcription factors has provided many opportunities for therapeutic intervention in a variety of pathophysiological conditions. A major question now is how many additional drug targets can be identified within this class of proteins. Advances in differential gene expression (DGE) technologies allow powerful new approaches to answer this question. Although DGE analysis is but one of several modern approaches to target identification, it is especially pertinent for nuclear receptors because many of these proteins are ligand-regulated transcription factors that directly alter gene expression. This article will focus on recent DGE experiments that have elucidated the physiological role of nuclear receptors in regulation of the bile acid biosynthesis, transport, and metabolism in the liver. Of particular relevance is the role of nuclear receptors in regulating CYP7A1 because this gene encodes the enzyme controlling the first and rate-limiting step in cholesterol degradation to bile acids. Modulation of CYP7A1 expression could provide a therapeutic benefit for multiple disease conditions. This article will focus on the relative contributions of farnesoid X-activated receptor, liver receptor homologous protein-1, small heterodimer partner, pregnane X receptor, and liver X receptor to the regulation of this specific gene, and bile acid metabolism in general. These studies highlight the dynamic interplay between nuclear receptors in the regulation of specific metabolic pathways.

    DOI: 10.1615/CritRevEukaryotGeneExpr.v12.i2.30

    Download article, 17 pages

    Article price - $35.00  

    Add to shopping cart

    << Previous article   Next article >>

    Designed by offsiteteam Designed by offsiteteam Designed by offsiteteam
    Begell House Inc.
    50 Cross Highway,
    Redding, CT 06896
    TEL (203) 938 1300
    FAX (203) 938 1304
    orders@begellhouse.com